登录 | 注册    微信公众号  
搜索

Bevacizumab 分子别名

Bevacizumab 分子背景

A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.

Bevacizumab 前沿进展

消息提示

请输入您的联系方式,再点击提交!

确定